KR100694732B1 - Cf3-치환 피리미딘의 선택적 합성 - Google Patents
Cf3-치환 피리미딘의 선택적 합성 Download PDFInfo
- Publication number
- KR100694732B1 KR100694732B1 KR1020067004428A KR20067004428A KR100694732B1 KR 100694732 B1 KR100694732 B1 KR 100694732B1 KR 1020067004428 A KR1020067004428 A KR 1020067004428A KR 20067004428 A KR20067004428 A KR 20067004428A KR 100694732 B1 KR100694732 B1 KR 100694732B1
- Authority
- KR
- South Korea
- Prior art keywords
- amine
- lewis acid
- formula
- group
- groups
- Prior art date
Links
- 0 CC(C)(*)c1nc(N(*)*)ncc1C(F)(F)F Chemical compound CC(C)(*)c1nc(N(*)*)ncc1C(F)(F)F 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
Claims (14)
- 제1항에 있어서, X1 및 X2가 할라이드, 아릴술포네이트, 알킬술포네이트, 퍼 플루오로알킬술포네이트, 아릴술피네이트 또는 알킬술피네이트로 구성된 군으로부터 독립적으로 선택된 서로 같거나 다른 이탈기인 방법.
- 제2항에 있어서, X1 및 X2가 서로 같거나 다르며, 각각 독립적으로 할라이드인 방법.
- 제3항에 있어서, X1 및 X2가 클로라이드인 방법.
- 제1항에 있어서, 상기 아민(HNR3R4)이 방향족 아민이고, 피리미딘 10의 양에 대해 0.25-10 당량의 루이스 산이 사용되는 방법.
- 제1항에 있어서, 상기 아민(HNR3R4)이 방향족 아민이고, 피리미딘 10의 양에 대해 0.5-3 당량의 루이스 산이 사용되는 방법.
- 제5항에 있어서, 루이스 산이 Zn, Mg, Sn, Ti, Al, B, Li, Ag, 및 Cu로 구성된 군으로부터 선택된 금속 이온의 염인 방법.
- 제7항에 있어서, 상기 루이스 산이 Zn 또는 Mg의 염인 방법.
- 제7항에 있어서, 상기 루이스 산이 ZnCl2인 방법.
- 제1항에 있어서, 상기 아민(HNR3R4)이 지방족 아민이거나 루이스 산에 대해 여러자리 리간드로서 작용할 수 있는 방향족 아민이고, 피리미딘 10의 양에 대해 0.5-10 당량의 루이스 산이 사용되는 방법.
- 제1항에 있어서, 상기 아민(HNR3R4)이 지방족 아민이거나 루이스 산에 대해 여러자리 리간드로서 작용할 수 있는 방향족 아민이고, 피리미딘 10의 양에 대해 1-4 당량의 루이스 산이 사용되는 방법.
- 제10항에 있어서, 루이스 산이 Zn, Mg, Sn, Ti, Al, B, Li, Ag, 및 Cu로 구성된 군으로부터 선택된 금속 이온의 염인 방법.
- 제12항에 있어서, 상기 루이스 산이 Zn 또는 Mg의 염인 방법.
- 제12항에 있어서, 상기 루이스 산이 ZnCl2인 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50073303P | 2003-09-05 | 2003-09-05 | |
US60/500,733 | 2003-09-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060030918A KR20060030918A (ko) | 2006-04-11 |
KR100694732B1 true KR100694732B1 (ko) | 2007-03-14 |
Family
ID=34272990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067004428A KR100694732B1 (ko) | 2003-09-05 | 2004-08-24 | Cf3-치환 피리미딘의 선택적 합성 |
Country Status (24)
Country | Link |
---|---|
US (1) | US7122670B2 (ko) |
EP (1) | EP1663991B1 (ko) |
JP (1) | JP4842816B2 (ko) |
KR (1) | KR100694732B1 (ko) |
CN (1) | CN100465164C (ko) |
AR (1) | AR045557A1 (ko) |
BR (1) | BRPI0414059B8 (ko) |
CA (1) | CA2537373C (ko) |
CO (1) | CO5650237A2 (ko) |
CY (1) | CY1106370T1 (ko) |
DE (1) | DE602004004287T2 (ko) |
DK (1) | DK1663991T3 (ko) |
ES (1) | ES2276344T3 (ko) |
HK (1) | HK1091824A1 (ko) |
IL (1) | IL173363A (ko) |
MX (1) | MXPA06002552A (ko) |
NO (1) | NO334383B1 (ko) |
NZ (1) | NZ544969A (ko) |
PL (1) | PL1663991T3 (ko) |
PT (1) | PT1663991E (ko) |
RU (1) | RU2315759C2 (ko) |
TW (1) | TWI283667B (ko) |
WO (1) | WO2005023780A1 (ko) |
ZA (1) | ZA200600747B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL379330A1 (pl) * | 2002-12-20 | 2006-08-21 | Pfizer Products Inc. | Pochodne pirymidyny dla leczenia nienormalnego wzrostu komórek |
US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
JP4778717B2 (ja) * | 2005-03-25 | 2011-09-21 | 富士フイルム株式会社 | 複素環式化合物の製造方法 |
DE102007010801A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
WO2008129380A1 (en) * | 2007-04-18 | 2008-10-30 | Pfizer Products Inc. | Sulfonyl amide derivatives for the treatment of abnormal cell growth |
KR101294731B1 (ko) * | 2007-06-04 | 2013-08-16 | 삼성디스플레이 주식회사 | 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법 |
JP2011515372A (ja) * | 2008-03-20 | 2011-05-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ピリミジン類の位置選択的製造法 |
UY31714A (es) * | 2008-03-20 | 2009-11-10 | Boehringer Ingelheim Int | Preparación selectiva de pirimidinas sustituidas |
DE102009006643A1 (de) | 2009-01-29 | 2010-08-05 | Saltigo Gmbh | Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten |
TW201100441A (en) * | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
US8933227B2 (en) * | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
EP2464633A1 (en) * | 2009-08-14 | 2012-06-20 | Boehringer Ingelheim International GmbH | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
EP2646448B1 (en) | 2010-11-29 | 2017-08-30 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
US8546443B2 (en) | 2010-12-21 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Benzylic oxindole pyrimidines |
EP2675793B1 (en) | 2011-02-17 | 2018-08-08 | Cancer Therapeutics Crc Pty Limited | Fak inhibitors |
CN103534240B (zh) | 2011-02-17 | 2015-12-09 | 癌症疗法Crc私人有限公司 | 选择性fak抑制剂 |
WO2014126954A1 (en) | 2013-02-13 | 2014-08-21 | OSI Pharmaceuticals, LLC | Regioselective synthesis of substituted pyrimidines |
JP6637880B2 (ja) * | 2014-05-08 | 2020-01-29 | 東ソー・ファインケム株式会社 | 5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 |
JP6391985B2 (ja) * | 2014-05-16 | 2018-09-19 | 東ソー・ファインケム株式会社 | 2−置換−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 |
JP6391988B2 (ja) * | 2014-05-21 | 2018-09-19 | 東ソー・ファインケム株式会社 | 5−(トリフルオロメチル)ピリミジン誘導体の製造方法及び新規5−(トリフルオロメチル)ピリミジン誘導体 |
CN108440499A (zh) * | 2018-03-22 | 2018-08-24 | 盐城师范学院 | 一种色瑞替尼及其关键中间体的制备方法 |
CN114213339B (zh) * | 2021-12-20 | 2023-10-31 | 苏州康纯医药科技有限公司 | 一种表皮细胞生长因子受体突变抑制剂的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2090571B1 (de) * | 2001-10-17 | 2012-05-16 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung |
-
2004
- 2004-08-24 ES ES04769170T patent/ES2276344T3/es active Active
- 2004-08-24 DK DK04769170T patent/DK1663991T3/da active
- 2004-08-24 PL PL04769170T patent/PL1663991T3/pl unknown
- 2004-08-24 KR KR1020067004428A patent/KR100694732B1/ko active IP Right Grant
- 2004-08-24 RU RU2006106727/04A patent/RU2315759C2/ru not_active IP Right Cessation
- 2004-08-24 MX MXPA06002552A patent/MXPA06002552A/es active IP Right Grant
- 2004-08-24 EP EP04769170A patent/EP1663991B1/en active Active
- 2004-08-24 CN CNB2004800254318A patent/CN100465164C/zh active Active
- 2004-08-24 PT PT04769170T patent/PT1663991E/pt unknown
- 2004-08-24 DE DE602004004287T patent/DE602004004287T2/de active Active
- 2004-08-24 JP JP2006525198A patent/JP4842816B2/ja active Active
- 2004-08-24 NZ NZ544969A patent/NZ544969A/en unknown
- 2004-08-24 CA CA002537373A patent/CA2537373C/en active Active
- 2004-08-24 BR BRPI0414059A patent/BRPI0414059B8/pt active IP Right Grant
- 2004-08-24 WO PCT/IB2004/002744 patent/WO2005023780A1/en active IP Right Grant
- 2004-08-27 US US10/928,954 patent/US7122670B2/en active Active
- 2004-09-02 AR ARP040103140A patent/AR045557A1/es not_active Application Discontinuation
- 2004-09-03 TW TW093126748A patent/TWI283667B/zh active
-
2006
- 2006-01-25 IL IL173363A patent/IL173363A/en active IP Right Grant
- 2006-01-26 ZA ZA200600747A patent/ZA200600747B/xx unknown
- 2006-02-23 CO CO06018320A patent/CO5650237A2/es not_active Application Discontinuation
- 2006-04-03 NO NO20061509A patent/NO334383B1/no unknown
- 2006-11-09 HK HK06112349.7A patent/HK1091824A1/xx unknown
-
2007
- 2007-03-12 CY CY20071100341T patent/CY1106370T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100694732B1 (ko) | Cf3-치환 피리미딘의 선택적 합성 | |
CN101084197B (zh) | 制备罗苏伐他汀的方法 | |
KR20080024538A (ko) | 로수바스타틴 및 중간체의 제조 방법 | |
EP2752407A1 (en) | Crystalline rosuvastatin calcium trihydrate | |
JP2010511029A (ja) | ロスバスタチンの製造方法 | |
CA3070069C (en) | Improved process for preparing aminopyrimidine derivatives | |
EP2350025A1 (en) | An improved process for preparing pyrimidine propenaldehyde | |
JPH04321677A (ja) | 新規の2−メトキシフェニルピペラジン誘導体 | |
KR20010015787A (ko) | 테트라히드로피리도피리미디논의 제3 위치 치환 유도체,그의 제조 방법 및 용도 | |
AU2004270480B2 (en) | Selective synthesis of CF3-substituted pyrimidines | |
TWI432435B (zh) | 作為合成中間物之噻唑基-吡唑并嘧啶化合物及相關合成方法 | |
JPH05279344A (ja) | N−5保護した2,5−ジアミノ−4,6−ジクロロピリミジンおよびその製造方法 | |
JPH05202054A (ja) | アミノメチル置換2,3−ジヒドロピラノ〔2,3−b〕ピリジン類 | |
AU735102B2 (en) | Improved process for the preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds | |
Shaker | Synthesis and characterization of some new 4, 4′‐(1, 4‐phenylene) dipyrimidine and 6, 6′‐(1, 4‐phenylene)‐di (pyridin‐2 (1H)‐one) derivatives | |
EP1928857B1 (en) | Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives | |
Terentjeva et al. | Synthesis 6-perfluoroalkylpyrimidine analogues of imatinib | |
Baranowski | Synthesis of heterocyclic CNS agents | |
MXPA97001505A (en) | Procedure for the preparation of compounds of 4, 6-bis (ariloxi) pyrimidine asimetri |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130403 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140225 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150226 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160224 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180305 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200226 Year of fee payment: 14 |